Drug intelligence / Profile preview

Amortivo

Development stage
Unknown
Lead developer
Activo Health
Modality
Small Molecules
Administration
Topical
01

Overview

Amortivo is a 5% medicated nail lacquer containing amorolfine hydrochloride, a morpholine antifungal agent. Marketed by Activo Health in South Africa, it is indicated for the treatment of onychomycosis (fungal nail infections) caused by dermatophytes, yeasts, and molds. Amorolfine exerts its antifungal activity by inhibiting two enzymes involved in the ergosterol biosynthesis pathway: sterol 14-reductase and cholestenol delta-isomerase. This dual inhibition leads to the depletion of ergosterol and the accumulation of atypical sterols (such as ignosterol) in the fungal cell membrane, resulting in altered membrane permeability and fungal cell death. The product is applied topically to the affected nails, where it penetrates the nail plate to reach the site of infection.

Brand names
Amortivo
Other names
Amortivo 5% Medicated Nail Lacquer
02

Targets

TM7SF2 (Sterol 14-reductase)EBP (Sterol isomerase (emopamil-binding protein))

Beyond the preview

Go deeper on Amortivo.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Amortivo.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call